Kindos`s Generics Fluorouracil Receives Approval in US
24 Sep 2024 //
FDA
Encube Ethicals` Generic Fluorouracil Receives Approval in the U.S.
02 Nov 2023 //
FDA
Alembic`s Generic Fluorouracil Receives Approval in the U.S.
18 Oct 2023 //
FDA
FOLFOX Produces Varying Toxicity Profile vs Chemoradiation in Rectal Cancer
01 Jul 2023 //
ONCLIVE
Alembic Pharma gets USFDA nod for Fluorouracil Injection USP, 2.5 g/50 Ml
06 Mar 2023 //
EXPRESS PHARMA
Enforcement Report - Week of February 1, 2023
01 Feb 2023 //
FDA
Merck Provides Update on Phase 3 KEYNOTE-921
03 Aug 2022 //
BUSINESSWIRE
Ipsen Announces Results from Phase III RESILIENT Trial Evaluating Onivyde
03 Aug 2022 //
BUSINESSWIRE
Accord Hlthcare`s Generic Fluorouracil Receives Approval In US
14 Oct 2021 //
FDA
Merck receives European approval for Keytruda in combo with chemotherapy
01 Jul 2021 //
PHARMABIZ
Amgen Announced Updated results from the Phase 2 FIGHT trial
07 Jun 2021 //
PRNEWSWIRE
EMA recommendations on DPD testing prior to treatment with fluorouracil
01 May 2020 //
EMA
Ingenus Pharms`s Generic Fluorouracil Receives Approval in US
13 Dec 2019 //
FDA
Merck Receives Positive EU CHMP Opinion for Two New Regimens of KEYTRUDA®
19 Oct 2019 //
BIOSPACE
Enforcement Report - Week of July 24, 2019
24 Jul 2019 //
FDA
EMA Begins Review of Screening Patients Before Fluorouracil
15 Mar 2019 //
RAPS
EMA Approved 5 fluorouracil List of nationally authorised medicinal products
19 Nov 2018 //
EMA
DFB Soria Completes a Ph2 Trial of Submicron Particle Paclitaxel Anhy for AK
18 Sep 2018 //
BUSINESSWIRE
Merck claims a win for Keytruda with interim OS data in H&NC
24 Jul 2018 //
ENDPTS
China slashes value added tax on over 100 cancer drugs
30 Apr 2018 //
PLATFORM
Gland Pharma’s Generic Fluorouracil Receives Approval In US
31 Oct 2017 //
FDA
Enforcement Report - Week of March 22, 2017
22 Mar 2017 //
FDA
Tocagen begins enrolling patients in Toca 5 phase 2/3 trial in South Korea
16 Jan 2017 //
PHARMABIZ
NICE Rejects Shire’s Pancreatic Cancer Drug
17 Nov 2016 //
PHARMATIMES
Merrimack, Baxalta Announce Initiation of Phase 1 Study of MM-151 with ONIVYDE
19 May 2016 //
PR NEWSWIRE
PharmaEngine Announces Korean Ministry of Food and Drug Safety Accepted ONIVYDE
10 May 2016 //
PR NEWSWIRE
High Ester Pectin Based Formulation for Site Specific Delivery of 5-Fluorouracil in to Descending Colon
03 May 2016 //
PHARMA-EXCIPIENTS
Sagent Pharm`s Generic Fluorouracil approved in US for treatment of cancer
17 Feb 2016 //
FDA
Updated Data Shows ONIVYDE® Combination Regimen Increased One Year Survival
19 Jan 2016 //
PR NEWS WIRE
Merrimack to Present Overall Survival Analysis of Ph3 NAPOLI-1 Study of ONIVYDE
11 Jan 2016 //
PR NEWS WIRE
Attix Pharmaceuticals Recalls Hundreds of APIs From the U.S.
02 May 2015 //
FIERCE PHARMA MFG
Lilly`s CYRAMZA® (Ramucirumab) Receives Supplemental Approval in USA for Cancer
25 Apr 2015 //
LILLY
Colorectal Cancer: What You Should Know
21 Apr 2015 //
FDA